Dynamic Gd-DTPA enhanced MRI as a surrogate marker of angiogenesis in tissue-engineered bladder constructs: A feasibility study in rabbits

Journal of Magnetic Resonance Imaging

Volumn 21, Issue 4, 2005, Pages 415-423

  Cheng, Hai Ling Margaret ^a,b,c   Chen, Jun ^b   Babyn, Paul S ^a   Farhat, Walid A ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Angiogenesis; Dynamic contrast enhanced MRI; Microvascular density; Perfusion; Permeability; Tissue engineering

Indexed keywords

GADOLINIUM PENTETATE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLADDER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; IMAGING SYSTEM; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT; TISSUE ENGINEERING; WHOLE BODY SCANNER;

ANIMALS; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; GADOLINIUM DTPA; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; NEOVASCULARIZATION, PHYSIOLOGIC; RABBITS; TISSUE ENGINEERING; URINARY BLADDER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 15944368543     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20278     Document Type: Article

References (40)

1. Garfein ES, Orgill DP, Pribaz JJ. Clinical applications of tissue engineered constructs. Clin Plast Surg 2003;30:485-498.
2. Atala A. Tissue engineering, stem cells, and cloning for the regeneration of urologic organs. Clin Plast Surg 2003;30:649-667.
3. Zisch AH, Lutolf MP, Hubbell JA. Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc Pathol 2003;12:295-310.
4. Nor JE, Peters MC, Christensen JB, et al. Engineering and characterization of functional human microvessels in immunodeficient mice. Lab Invest 2001;81:453-463.
5. Jain RK, Schlenger K, Hockel M, Yuan F. Quantitative angiogenesis assays: progress and problems. Nat Med 1997;3:1203-1208.
6. Artacho-Perula E, Roldan-Villalobos R, Cruz-Orive LM. Application of the fractionator and vertical slices to estimate total capillary length in skeletal muscle. J Anat 1999;195:429-437.
7. Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 2003;17:509-520.
8. Reddick WE, Taylor JS, Fletcher BD. Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma. J Magn Reson Imaging 1999;10:277-285.
9. Knopp MV, Weiss E, Sinn HP, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 1999;10:260-266.
10. Mayr NA, Hawighorst H, Yuh WT, Essig M, Magnotta VA, Knopp MV. MR microcirculation assessment in cervical cancer: correlations with histomorphological tumor markers and clinical outcome. J Magn Reson Imaging 1999;10:267-276.
11. Barentsz JO, Engelbrecht M, Jager GJ, et al. Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancer. J Magn Reson Imaging 1999;10:295-304.
12. Neves AA, Medcalf N, Brindle KM. Tissue engineering of meniscal cartilage using perfusion culture. Ann NY Acad Sci 2002;961:352-355.
13. Hartman EH, Pikkemaat JA, Vehof JW, Heerschap A, Jansen JA, Spauwen PH. In vivo magnetic resonance imaging explorative study of ectopic bone formation in the rat. Tissue Eng 2002;8:1029-1036.
14. Koretsky AP. Functional assessment of tissues with magnetic resonance imaging. Ann NY Acad Sci 2002;961:203-205.
15. Taylor JS, Tofts PS, Port R, et al. MR imaging of tumor microcirculation: promise for the new millennium. J Magn Reson Imaging 1999;10:903-907.
16. Li KL, Zhu XP, Waterton J, Jackson A. Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. J Magn Reson Imaging 2000;12:347-357.
17. Kuhl CK, Klaschik S, Mielcarek P, Gieseke J, Wardelmann E, Schild HH. Do T2-weighted pulse sequences help with the differential diagnosis of enhancing lesions in dynamic breast MRI? J Magn Reson Imaging 1999;9:187-196.
18. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101.
19. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991;17:357-367.
20. Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 1999;10:254-259.
21. Look DC, Locker DR. Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum 1970;41:250-251.
22. Kay I, Henkelman RM. Practical implementation and optimization of one-shot T1 imaging. Magn Reson Med 1991;22:414-424.
23. Cheng HL, Purcell CM, Bilbao JM, Plewes DB. Prediction of subtle thermal histopathological change using a novel analysis of Gd-DTPA kinetics. J Magn Reson Imaging 2003;18:585-598.
24. Cheng HL, Purcell CM, Bilbao JM, Plewes DB. Usefulness of contrast kinetics for predicting and monitoring tissue changes in muscle following thermal therapy in long survival studies. J Magn Reson Imaging 2004;19:329-341.
25. Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996;200:639-649.
26. Flickinger FW, Allison JD, Sherry RM, Wright JC. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast-enhanced MRI. Magn Reson Imaging 1993;11:617-620.
27. Stack JP, Redmond OM, Codd MB, Dervan PA, Ennis JT. Breast disease: tissue characterization with Gd-DTPA enhancement profiles. Radiology 1990;174:491-494.
28. Leach MO, Brindle KM, Evelhoch JL, et al. Assessment of anti-angiogenic and anti-vascular therapeutics using magnetic resonance imaging: recommendations for appropriate methodology for clinical trials. In: Proceedings of the 11th Annual Meeting of ISMRM, Toronto, Canada, 2003.
29. Helbich TH, Roberts TP, Gossmann A, et al. Quantitative gadopentetate-enhanced MRI of breast tumors: testing of different analytic methods. Magn Reson Med 2000;44:915-924.
30. Su MY, Cheung YC, Fruehauf JP, et al. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer. J Magn Reson Imaging 2003;18:467-477.
31. Toi M, Inada K, Hoshina S, Suzuki H, Kondo S, Tominaga T. Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Clin Cancer Res 1995;1:961-964.
32. Hulka CA, Smith BL, Sgroi DC, et al. Benign and malignant breast lesions: differentiation with echo-planar MR imaging. Radiology 1995;197:33-38.
33. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-232.
34. Shalabi A, Kristoffersen-Wiberg M, Papadogiannakis N, Aspelin P, Movin T. Dynamic contrast-enhanced MR imaging and histopathology in chronic achilles tendinosis. A longitudinal MR study of 15 patients. Acta Radiol 2002;43:198-206.
35. Galbraith SM, Maxwell RJ, Lodge MA, et al. Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging. J Clin Oncol 2003;21:2831-2842.
36. Robinson SP, McIntyre DJ, Checkley D, et al. Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging. Br J Cancer 2003;88:1592-1597.
37. Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 2002;16:407-422.
38. Kuhl CK, Schild HH. Dynamic image interpretation of MRI of the breast. J Magn Reson Imaging 2000;12:965-974.
39. Galbraith SM, Lodge MA, Taylor NJ, et al. Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis. NMR Biomed 2002;15:132-142.
40. de Lussanet QG, Backes WH, Griffioen AW, van Engelshoven JM, Beets-Tan RG. Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice. Radiology 2003;229:429-438.